Quarter Financials
Relmada Therapeutics, Inc. (RLMD)
$3.01
+0.01 (+0.33%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -25 | -24 | -37 | -40 | -34 | -41 | -34 | -43 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -514 | -488 | -462 | -424 | -385 | -345 | -305 | -271 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | - | - | - | - | - | - | - | - |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | -26 | -141 | -26 | -7 | -6 | -8 | -35 | -11 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|